Effect of chlorhexidine, povidone-iodine, and hydrogen peroxide irrigation on pain and swelling after mandibular third molar surgery: randomized controlled trial
International Journal of Oral and Maxillofacial Surgery · 2025
DOI: 10.1016/j.ijom.2025.01.021 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Oral and Maxillofacial Surgery, 2025. Verfasst von M Shahraki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Zahedan University of Medical Sciences, Zahedan, Iran. Hauptthemen laut MEDLINE: Povidone-Iodine, Chlorhexidine, Molar, Third, Hydrogen Peroxide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
The objective of this study was to compare the effects of irrigation solutions containing chlorhexidine, povidone-iodine, or hydrogen peroxide on pain and swelling following mandibular third molar surgery. This prospective randomized controlled trial employed a single-blind design. Overall, 112 patients were randomized to four groups based on the antiseptic assigned for the intervention: control, chlorhexidine (CHX), povidone-iodine (PI), and hydrogen peroxide (HP). The patients were followed up on days 1, 3, 7, and 15 after surgery, and pain and swelling were assessed. Data were analysed using ANOVA and post hoc multiple comparison tests. The CHX and HP groups demonstrated significantly lower mean pain scores compared to the control group on days 3 (P = 0.021, P = 0.033) and 7 (P = 0.002, P = 0.017). Regarding the difference in swelling from baseline (before surgery) on each follow-up day, the CHX and HP groups showed significantly less swelling compared to the control group on days 1 (P = 0.023, P = 0.012), 3 (P = 0.007, P = 0.001), and 7 (P = 0.002, P = 0.018). Moreover, the CHX and HP groups demonstrated significantly lower mean swelling changes from baseline compared to PI: CHX vs PI on day 7 (P = 0.032), HP vs PI on day 1 (P = 0.037). In conclusion, chlorhexidine and hydrogen peroxide solutions are highly beneficial options for socket irrigation following mandibular third molar surgery. This study showed a more prominent reduction in pain and swelling with chlorhexidine and hydrogen peroxide solutions compared to povidone-iodine solution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Zahedan University of Medical Sciences, Zahedan, Iran.
- Oral and Dental Disease Research Centre, Faculty of Dentistry, Zahedan University of Medical Sciences, Zahedan, Iran.
- Department of Periodontics and Preventive Dentistry, University of Pittsburgh School of Dental Medicine, Pittsburgh, PA, USA.
- Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Zahedan University of Medical Sciences, Zahedan, Iran. Electronic address: sadraharadasht@gmail.com.
Zitieren
APA
Shahraki, M., Khazaei, A. H., Hakimi, S., Hasheminasab, M., & Haradasht, S. A. (2025). Effect of chlorhexidine, povidone-iodine, and hydrogen peroxide irrigation on pain and swelling after mandibular third molar surgery: randomized controlled trial. International Journal of Oral and Maxillofacial Surgery. https://doi.org/10.1016/j.ijom.2025.01.021
Vancouver
Shahraki M, Khazaei AH, Hakimi S, Hasheminasab M, Haradasht SA. Effect of chlorhexidine, povidone-iodine, and hydrogen peroxide irrigation on pain and swelling after mandibular third molar surgery: randomized controlled trial. International Journal of Oral and Maxillofacial Surgery. 2025. doi:10.1016/j.ijom.2025.01.021
BibTeX
@article{Shahraki2025,
author = {Shahraki, M and Khazaei, A H and Hakimi, S and Hasheminasab, M and Haradasht, S A},
title = {Effect of chlorhexidine, povidone-iodine, and hydrogen peroxide irrigation on pain and swelling after mandibular third molar surgery: randomized controlled trial},
journal = {International Journal of Oral and Maxillofacial Surgery},
year = {2025},
doi = {10.1016/j.ijom.2025.01.021}
}
EUVIMED